Extended Access of Momelotinib in Adults With Myelofibrosis
GlaxoSmithKline
GlaxoSmithKline
National Cancer Institute (NCI)
Karyopharm Therapeutics Inc
Incyte Corporation
iOnctura
Novartis
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Center for International Blood and Marrow Transplant Research
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
AbbVie
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
Geron Corporation
City of Hope Medical Center
Bristol-Myers Squibb
City of Hope Medical Center
AbbVie
Celgene
City of Hope Medical Center
City of Hope Medical Center
Italfarmaco
AbbVie
Stichting Hemato-Oncologie voor Volwassenen Nederland